Millennium Management
INDV icon

Millennium Management’s Indivior Pharmaceuticals INDV Stock Holding History

Millennium Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-150,000
Closed -$5.38M – 6017
2025
Q4 		$5.38M Buy
+150,000
New +$4.58M ﹤0.01% 2928
2025
Q3 		– Sell
-107,200
Closed -$1.58M – 6225
2025
Q2 		$1.58M Buy
107,200
+27,900
+35% +$325K ﹤0.01% 4078
2025
Q1 		$756K Buy
+79,300
New +$834K ﹤0.01% 4559

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's INDV Position: Q1 2026 in Review

Millennium Management increased its Indivior Pharmaceuticals (INDV) stake by 97% in Q1 2026, buying an estimated $74.6M and bringing the position to 4,595,535 shares worth $140M. The position accounts for 0.06% of the portfolio, ranked #322.

Millennium Management first reported a position in INDV in Q1 2024 and has held it in 9 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Millennium Management held 4,595,535 shares of Indivior Pharmaceuticals worth $140M as of Q1 2026.
  • Millennium Management bought 2,257,850 Indivior Pharmaceuticals shares in Q1 2026, an estimated $74.6M.
  • Indivior Pharmaceuticals made up 0.06% of Millennium Management's portfolio in Q1 2026, its #322 holding.
  • Millennium Management first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.